Acute adriamycin cardiotoxicity in rats

Area of Science:

• Cardiovascular Pharmacology
• Toxicology
• Biochemistry

Background:

• Adriamycin (ADR) is an effective chemotherapeutic agent but can cause significant cardiotoxicity.
• The precise mechanisms underlying ADR-cardiotoxicity, particularly the role of lipid peroxidation, require further elucidation.

Purpose of the Study:

• To investigate the occurrence and pathogenic role of in vivo heart lipoperoxidation during acute ADR-cardiotoxicity in a rat model.
• To correlate findings of lipoperoxidation with cardiac ultrastructural changes and biochemical markers.

Main Methods:

• Male Wistar rats received a single intravenous dose of ADR (15 mg/kg) or saline (control).
• Cardiac tissue and serum were analyzed at 24 and 96 hours post-treatment.
• Evaluated parameters included serum creatine kinase, cardiac DNA, RNA, protein, catalase, GSH-Px activity, malonaldehyde production, and in vivo lipoperoxidation (diene conjugation).
• Cardiac myocyte ultrastructure was examined using electron microscopy.

Main Results:

• Serum creatine kinase levels were significantly elevated in ADR-treated rats at 96 hours.
• Significant ultrastructural changes, including mitochondrial swelling and myofilament fragmentation, were observed in cardiac myocytes.
• In vivo lipoperoxidation was detected in a limited number of ADR-treated rats, with no clear correlation to cardiac damage.

Conclusions:

• Lipoperoxidation does not appear to play a fundamental role in the pathogenesis of acute Adriamycin-induced cardiotoxicity in rats.
• ADR-cardiotoxicity is characterized by significant ultrastructural damage to cardiac myocytes, independent of widespread in vivo lipoperoxidation.